COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on APONTIS PHARMA AG with a Buy rating and EUR 17.00 price target. Apontis focuses on cardiovascular and respiratory drugs in Germany, led by CEO Wohlschlegel to drive efficiency and growth -
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Provides Update on 2024 Exploration Plan - Initiates Diamond Drill Program on High Grade Target
EV Nickel Inc. (TSX-V:EVNI) provides update on 2024 Exploration Plan, diamond drilling on Langmuir #2 high priority nickel target. Expanding activities on CarLang resource, drilling high-grade targets, advancing clean metal bioleaching program -
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Surface Sample Program Identifies Significant Extension Of Large-Scale Nickel Mineralization Along The Carlang Trend
EV Nickel Inc. announces positive assay results from 148 surface samples at the CarLang Trend in its Shaw Dome Project. Potential for large contiguous nickel mineralization. Expansion of sampling program planned
